Global Burden of Disease Study 2021 (GBD 2021) Smoking Mortality and Prevalence Forecasts 2022-2050

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories. This dataset provides annual estimates for deaths and years of life lost (YLLs) for 2022-2050 in three smoking prevalence scenarios. Data sources used to produce the estimates came from GBD 2019 and GBD 2021 analyses.

由健康指标与评估研究所（Institute for Health Metrics and Evaluation，IHME）统筹开展的2021年全球疾病负担研究（Global Burden of Disease Study 2021，GBD 2021），针对204个国家和地区的疾病、伤害及危险因素负担完成了量化评估。本数据集提供了2022年至2050年三种吸烟流行率场景下的死亡与寿命损失年（Years of Life Lost，YLLs）年度估算值。用于生成该估算值的数据源，均取自2019年全球疾病负担研究（GBD 2019）与2021年全球疾病负担研究（GBD 2021）的分析结果。